Valeant Pharma (VRX) Shares See Early Bounce Higher

November 9, 2016 8:56 AM EST

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.

Valeant Pharma (NYSE: VRX) shares are ticking higher early following a 22 percent drop on Monday amid weak Q3 results and cut outlook. The stock is up well over 2 percent ahead of the opening bell, going against broader market pressure.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Short Sales, Trader Talk

Add Your Comment